tirzepatide availability us Lilly's Zepbound (aka tirzepatide) Lands FDA Approval for Weight Loss Lilly releases Zepbound® (tirzepatide) single-dose

In animal studies, AOD-9604 reduced body weight gain by over 50% in obese mice during a 19-day treatment period, and significantly increased fat oxidation all without affecting insulin sensitivity or glucose regulation.[1,3] A randomized controlled trial in humans found that participants taking 1 mg of AOD-9604 daily lost an average of 2.8 kg (~6 lbs) over 23 weeks, compared to 0.8 kg (~1.7 lbs) in the placebo group

doi: 10.3346/jkms.2011.26.8.1093 46

38, 2021, pp

GLP-1s Can Affect Fertility This may happen because the metabolic improvements caused by GLP-1s can help restore ovulation, especially for women with insulin resistance or polycystic ovary syndrome (PCOS), Gandhi says

High-dose omega-3 prescriptions (like Vascepa or Lovaza) reduce VLDL and triglycerides significantly

Homocysteine as a potential predictive factor for high major adverse cardiovascular events risk in female patients with premature acute coronary syndrome